跳至主要内容
临床试验/NL-OMON26482
NL-OMON26482尚未招募不适用

Desensitization of highly pre-sensitized dialysis patients waiting for kidney transplantation by Rituximab, IVIG-L and rescue Plasmapheresis

Dr. Ajda T. Rowshani; Nephrologist-Clinical ImmunologistAcademic Medical CenterDepartment of Internal Medicine, F4-215PO Box 22700100 DE Amsterdam, The NetherlandsTel: +31-20-5663365 page 58816Fax: +31-20-6914904E-mail:T.Rowshani@AMC.UVA.0 个研究点目标入组 17 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
17

研究概览

简要总结

ot applicable.

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients older than 18 years with end stage renal failure and a current PRA higher than 80 % who are for more than two years on the waiting list for a cadaveric donor kidney, and included in the AM program. Only heart beating donors will be accepted.

排除标准

  • A. Complete IgA deficiency
  • B. Overhydration
  • C. History of anaphylaxis against blood/plasma products
  • D. Significant cardiac or pulmonary disease, hepatitis C or HIV infection, or malignancy
  • within the last 5 years

研究者

发起方
Dr. Ajda T. Rowshani; Nephrologist-Clinical ImmunologistAcademic Medical CenterDepartment of Internal Medicine, F4-215PO Box 22700100 DE Amsterdam, The NetherlandsTel: +31-20-5663365 page 58816Fax: +31-20-6914904E-mail:T.Rowshani@AMC.UVA.

相似试验